Elite Pharmaceuticals (OTCMKTS:ELTP – Get Free Report) posted its quarterly earnings data on Monday. The specialty pharmaceutical company reported $0.01 earnings per share for the quarter. Elite Pharmaceuticals had a negative net margin of 25.70% and a negative return on equity of 6.92%.
Source link
Thought I’d start a dedicated thread where we can voice our opinions on individual (or sectors) stocks that have a good chance of rising from their current position. Preferably with a good outline of why we think that way and whether it’s held or not or planning to be held. I guess for the benefit…
December 24, 2025December 24, 2025 In a fresh development on India–Gulf trade ties, the Gulf Cooperation Council (GCC) has agreed to separate talks on a Bilateral Investment Treaty (BIT) from the Terms of Reference (ToR) for a Free Trade Agreement (FTA). According to sources, the ToR lays down the…
Figured we needed a shrinkflation thread. 2 things have urked me lately, in regards to said thread title. As an Australian, I find reprehensible to buy a meat pie and find it only half filled. What a joke.A first for me. As much air space in there as filling.A couple of weeks ago was a…
When we left you on Friday the bombs were bursting in air. Trump with a salvo: “The easiest way to save money in our Budget, Billions and Billions of Dollars, is to terminate Elon’s Governmental Subsidies and Contracts. I was always surprised that Biden didn’t do it!” Replied Musk: “Go ahead, make my day.” Steve…
NEW DELHI: The Nifty Realty index traded positive around 10:46AM(IST)on Wednesday in an upbeat market. Raymond Ltd.(up 2.66 per cent), Phoenix Mills Ltd.(up 1.94 per cent), Oberoi Realty Ltd.(up 1.87 per cent), Macrotech Developers Ltd.(up 1.83 per cent) and Anant Raj Ltd.(up 1.66 per cent) were among the top gainers. Brigade Enterprises Ltd.(down 1.12 per…
Image source: Getty Images The Toronto Stock Exchange endured the U.S.-initiated tariff war in 2025, even surpassing the double-digit returns of 2024. Some analysts believe Canadian stocks will again show resilience in 2026, though a repeat of the stellar performance is unlikely. Market conditions have changed, with the U.S. introducing new headwinds through a military…